Mantle Cell Lymphoma

general

A non-Hodgkin lymphoma composed of small to medium sized B-lymphocytes (centrocytes). Most patients present with advanced stage disease with lymphadenopathy, hepatosplenomegaly, and bone marrow involvement. The gastrointestinal tract is the most commonly affected extranodal site by this type of non-Hodgkin lymphoma. The vast majority of cases express the t(11;14)(q13;q32) resulting in the rearrangement of the BCL-1 gene and the overexpression of cyclin D1 mRNA.

91

Centers

317

Active Trials

$1.3B

Cancer Funding

Specific Cancer Types(6)

Top Centers for Mantle Cell Lymphoma(91)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
190.2
2
NCI Comprehensive
High-Volume Research Center
85.6
3
NCI Comprehensive
High-Volume Research Center
85.0
4
NCI Clinical
High-Volume Research Center
77.3
5
NCI Comprehensive
High-Volume Research Center
76.1
6
NCI Clinical
High-Volume Research Center
75.4
7
NCI Comprehensive
High-Volume Research Center
74.2
8
NCI Comprehensive
High-Volume Research Center
73.7
9
NCI Comprehensive
High-Volume Research Center
73.4
10
NCI Comprehensive
High-Volume Research Center
71.8
11
NCI Comprehensive
High-Volume Research Center
70.7
12
NCI Comprehensive
High-Volume Research Center
70.7
13
NCI Comprehensive
High-Volume Research Center
70.0
14
NCI Comprehensive
Active Research Program
69.2
15
Active Research Program
68.9
16
Active Research Program
68.1
17
NCI Comprehensive
Active Research Program
67.8
18
NCI Comprehensive
Active Research Program
67.5
19
NCI Comprehensive
Active Research Program
67.2
20
NCI Comprehensive
Active Research Program
65.9
21
NCI Comprehensive
Active Research Program
65.2
22
NCI Comprehensive
Active Research Program
64.1
23
NCI Comprehensive
Active Research Program
64.0
24
Active Research Program
63.1
25
NCI Comprehensive
Active Research Program
62.0
26
NCI Comprehensive
Active Research Program
61.9
27
Active Research Program
61.6
28
Active Research Program
61.2
29
NCI Comprehensive
Active Research Program
60.1
30
NCI Comprehensive
Active Research Program
59.5
31
NCI Comprehensive
Active Research Program
59.4
32
NCI Comprehensive
Active Research Program
57.1
33
Active Research Program
56.7
34
BC CancerVancouver, BC
Active Research Program
56.0
35
NCI Comprehensive
Active Research Program
55.3
36
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
53.9
37
NCI Comprehensive
Active Research Program
53.5
38
Active Research Program
53.4
39
Active Research Program
53.4
40
NCI Comprehensive
Active Research Program
52.8
41
NCI Comprehensive
Active Research Program
52.4
42
NCI Comprehensive
Active Research Program
52.0
43
NCI Clinical
Active Research Program
51.1
4451.0
45
Active Research Program
50.5
46
Active Research Program
49.8
47
NCI Comprehensive
Active Research Program
47.8
48
Active Research Program
47.0
49
NCI Clinical
Active Research Program
46.7
50
NCI Comprehensive
Active Research Program
45.6
51
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
45.3
52
GW Cancer CenterWashington, DC
Active Research Program
44.9
53
NCI Comprehensive
Active Research Program
44.3
54
NCI Comprehensive
Active Research Program
43.6
55
NCI Comprehensive
Active Research Program
43.5
56
Active Research Program
42.4
57
Active Research Program
42.4
5842.2
59
NCI Comprehensive
Active Research Program
41.7
60
NCI Comprehensive
Active Research Program
40.0
61
NCI Comprehensive
Active Research Program
38.0
62
Active Research Program
37.2
63
NCI Clinical
Active Research Program
36.4
64
NCI Comprehensive
Active Research Program
36.3
65
NCI Comprehensive
Active Research Program
36.0
66
NCI Comprehensive
Active Research Program
36.0
67
NCI Comprehensive
Active Research Program
36.0
68
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
36.0
69
Active Research Program
36.0
7036.0
71
Active Research Program
36.0
72
NCI Comprehensive
Active Research Program
35.1
73
NCI Comprehensive
Contributing Research Center
34.2
74
NCI Comprehensive
Contributing Research Center
33.5
75
Contributing Research Center
33.3
76
Contributing Research Center
32.8
77
Cedars-Sinai CancerLos Angeles, CA
Contributing Research Center
28.6
78
Contributing Research Center
28.6
79
NCI Clinical
Contributing Research Center
28.6
80
Contributing Research Center
28.6
81
NCI Basic_laboratory
Contributing Research Center
28.6
82
Contributing Research Center
28.6
83
Contributing Research Center
26.9
84
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Contributing Research Center
25.8
85
Contributing Research Center
24.2
86
NCI Comprehensive
Contributing Research Center
24.0
8720.7
8820.7
89
NCI Comprehensive
90
91

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →